Dermot Kelleher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dermot Kelleher has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Navin Kumar Verma
Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore
4 shared publications - Brandon Han Siang Wong
Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore
2 shared publications - Irene Rose Antony
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore
2 shared publications - John Vincent Reynolds
Trinity St. James’s Cancer Institute, Dublin, Ireland
2 shared publications Mohamed M.M. Abdel-Latif
2 shared publications- Shane Patrick Duggan
Division of Gastroenterology, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
2 shared publications
Latest Publications
- Open Access
- 7 June 2025
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 19 (10) , 101552
A Reflux Linked GATA Factor Fulcrum Dictates Lineage Commitment Through GPRC5B During the Esophageal Dysplastic Transition
- 7 June 2025
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 19 (10) , 101552
Open AccessA Reflux Linked GATA Factor Fulcrum Dictates Lineage Commitment Through GPRC5B During the Esophageal Dysplastic Transition
- Open Access
Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases
Immune surveillance and adaptive immune responses, involving continuously circulating and tissue-resident T-lymphocytes, provide host defense against infectious agents and possible malignant transformation while avoiding autoimmune tissue damage. Activation, migration, and deployment of T-cells to affected tissue sites are crucial for mounting an adaptive immune response. An effective adaptive immune defense depends on the ability of T-cells to dynamically reprogram their metabolic requirements in response to environmental cues. Inability of the T-cells to adapt to specific metabolic demands may skew cells to become either hyporesponsive (creating immunocompromised conditions) or hyperactive (causing autoimmune tissue destruction). Here, we review maladaptive T-cell metabolic fitness that can cause autoimmune diseases and discuss how T-cell metabolic programs can potentially be modulated to achieve therapeutic benefits.
Open AccessMaladaptive T-Cell Metabolic Fitness in Autoimmune Diseases
Immune surveillance and adaptive immune responses, involving continuously circulating and tissue-resident T-lymphocytes, provide host defense against infectious agents and possible malignant transformation while avoiding autoimmune tissue damage. Activation, migration, and deployment of T-cells to affected tissue sites are crucial for mounting an adaptive immune response. An effective adaptive immune defense depends on the ability of T-cells to dynamically reprogram their metabolic requirements in response to environmental cues. Inability of the T-cells to adapt to specific metabolic demands may skew cells to become either hyporesponsive (creating immunocompromised conditions) or hyperactive (causing autoimmune tissue destruction). Here, we review maladaptive T-cell metabolic fitness that can cause autoimmune diseases and discuss how T-cell metabolic programs can potentially be modulated to achieve therapeutic benefits.
- Open Access
- 28 September 2023
- Published by MDPI AG in Preprints.org
Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases
Immune surveillance and adaptive immune responses, involving continuously circulating and tissue-resident T-lymphocytes, provide host defense against infectious agents and possible malignant transformation while avoiding autoimmune tissue damage. Activation, migration, and deployment of T-cells to affected tissue sites are crucial for mounting an adaptive immune response. An effective adaptive immune defense depends on the ability of T-cells to dynamically reprogram their metabolic requirements in response to environmental cues. Inability of the T-cells to adapt to specific metabolic demands may skew cells to become either hyporesponsive creating immunocompromised conditions or hyperactive causing autoimmune tissue destruction. Here, we review maladaptive T-cell metabolic fitness that can cause autoimmune diseases and discuss how T-cell metabolic programs can potentially be modulated to achieve therapeutic benefits.
- 28 September 2023
- Published by MDPI AG in Preprints.org
Open AccessMaladaptive T-Cell Metabolic Fitness in Autoimmune Diseases
Immune surveillance and adaptive immune responses, involving continuously circulating and tissue-resident T-lymphocytes, provide host defense against infectious agents and possible malignant transformation while avoiding autoimmune tissue damage. Activation, migration, and deployment of T-cells to affected tissue sites are crucial for mounting an adaptive immune response. An effective adaptive immune defense depends on the ability of T-cells to dynamically reprogram their metabolic requirements in response to environmental cues. Inability of the T-cells to adapt to specific metabolic demands may skew cells to become either hyporesponsive creating immunocompromised conditions or hyperactive causing autoimmune tissue destruction. Here, we review maladaptive T-cell metabolic fitness that can cause autoimmune diseases and discuss how T-cell metabolic programs can potentially be modulated to achieve therapeutic benefits.
- Open Access
- 13 March 2020
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 441
Editorial: Adaptor Protein Regulation in Immune Signalling
Editorial: Adaptor Protein Regulation in Immune Signalling
- 13 March 2020
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 441
Open AccessEditorial: Adaptor Protein Regulation in Immune Signalling
Editorial: Adaptor Protein Regulation in Immune Signalling
- Open Access
- 1 January 2018
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 5 (4) , 569-590
siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth
- 1 January 2018
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 5 (4) , 569-590
Open AccesssiRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth
- 15 August 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 199 (4) , 1213-1221
Not Just an Adhesion Molecule: LFA-1 Contact Tunes the T Lymphocyte Program
The αLβ2 integrin LFA-1 is known to play a key role in T lymphocyte migration, which is necessary to mount a local immune response, and is also the main driver of autoimmune diseases. This migration-triggering signaling process in T cells is tightly regulated to permit an immune response that is appropriate to the local trigger, as well as to prevent deleterious tissue-damaging bystander effects. Emerging evidence shows that, in addition to prompting a diverse range of downstream signaling cascades, LFA-1 stimulation in T lymphocytes modulates gene-transcription programs, including genetic signatures of TGF-β and Notch pathways, with multifactorial biological outcomes. This review highlights recent findings and discusses molecular mechanisms by which LFA-1 signaling influence T lymphocyte differentiation into the effector subsets Th1, Th17, and induced regulatory T cells. We argue that LFA-1 contact with a cognate ligand, such as ICAM-1, independent of the immune synapse activates a late divergence in T cells’ effector phenotypes, hence fine-tuning their functioning.
- 15 August 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 199 (4) , 1213-1221
Not Just an Adhesion Molecule: LFA-1 Contact Tunes the T Lymphocyte Program
The αLβ2 integrin LFA-1 is known to play a key role in T lymphocyte migration, which is necessary to mount a local immune response, and is also the main driver of autoimmune diseases. This migration-triggering signaling process in T cells is tightly regulated to permit an immune response that is appropriate to the local trigger, as well as to prevent deleterious tissue-damaging bystander effects. Emerging evidence shows that, in addition to prompting a diverse range of downstream signaling cascades, LFA-1 stimulation in T lymphocytes modulates gene-transcription programs, including genetic signatures of TGF-β and Notch pathways, with multifactorial biological outcomes. This review highlights recent findings and discusses molecular mechanisms by which LFA-1 signaling influence T lymphocyte differentiation into the effector subsets Th1, Th17, and induced regulatory T cells. We argue that LFA-1 contact with a cognate ligand, such as ICAM-1, independent of the immune synapse activates a late divergence in T cells’ effector phenotypes, hence fine-tuning their functioning.
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A463-A464
5-Fluoruracil and cisplatin induce Nf-Kb, Ap-1 and COX-2 transcription in oesophageal epithelial cells: Role for PKC and MAPK signalling pathways involvement
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A463-A464
5-Fluoruracil and cisplatin induce Nf-Kb, Ap-1 and COX-2 transcription in oesophageal epithelial cells: Role for PKC and MAPK signalling pathways involvement